Donepezil fails to reduce agitation in people with dementiaBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.335.7623.744-c (Published 11 October 2007) Cite this as: BMJ 2007;335:744
Memory loss and other cognitive impairments are the hallmarks of dementia. But many patients are also agitated and confused, and these symptoms cause most distress to carers. Few effective drug treatments exist. Donepezil is the latest to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial